Ocular Therapeutix (OCUL) Payables (2013 - 2026)
Ocular Therapeutix's quarterly Payables came in at $8.0 million in Q1 2026, up 73.5% year-on-year from $4.6 million in Q1 2025, and up 93.21% quarter-over-quarter from $4.2 million in Q4 2025.
Ocular Therapeutix has reported Payables for 14 years, with the latest figure at $8.0 million in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 73.5% year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (up 73.5% YoY), and the FY2025 full-year result was $4.2 million, down 0.53% from the prior year.
- Payables for Q1 2026 stood at $8.0 million, up from $4.2 million in the prior quarter.
- The five-year high for Payables was $8.0 million in Q1 2026, with the low at $3.4 million in Q1 2022.
- Average Payables over 5 years is $5.0 million, with a median of $4.6 million recorded in 2025.
- Year-over-year, Payables plunged 72.51% in 2022 and jumped 73.5% in 2026.
- Tracing OCUL's Payables over 5 years: stood at $5.1 million in 2022, then slipped by 14.33% to $4.4 million in 2023, then fell by 4.85% to $4.2 million in 2024, then decreased by 0.53% to $4.2 million in 2025, then soared by 93.21% to $8.0 million in 2026.
- The last three Payables figures came in at $8.0 million (Q1 2026), $4.2 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 8.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.03 Mn |
| Dec 31, 2025 | 4.15 Mn |
| Sep 30, 2025 | 6.26 Mn |
| Jun 30, 2025 | 5.89 Mn |
| Mar 31, 2025 | 4.63 Mn |
| Dec 31, 2024 | 4.18 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 6.45 Mn |
| Dec 31, 2023 | 4.39 Mn |
| Sep 30, 2023 | 3.98 Mn |
| Jun 30, 2023 | 5.66 Mn |
| Mar 31, 2023 | 5.44 Mn |
| Dec 31, 2022 | 5.12 Mn |
| Sep 30, 2022 | 5.31 Mn |
| Jun 30, 2022 | 3.70 Mn |
| Mar 31, 2022 | 3.42 Mn |
| Dec 31, 2021 | 4.59 Mn |
| Sep 30, 2021 | 4.25 Mn |
| Jun 30, 2021 | 3.88 Mn |
| Mar 31, 2021 | 12.44 Mn |
| Dec 31, 2020 | 11.00 Mn |
| Sep 30, 2020 | 9.44 Mn |
| Jun 30, 2020 | 6.80 Mn |
| Mar 31, 2020 | 4.91 Mn |
| Dec 31, 2019 | 3.27 Mn |
| Sep 30, 2019 | 3.46 Mn |
| Jun 30, 2019 | 4.04 Mn |
| Mar 31, 2019 | 3.90 Mn |
| Dec 31, 2018 | 2.97 Mn |
| Sep 30, 2018 | 8.87 Mn |
| Jun 30, 2018 | 8.22 Mn |
| Mar 31, 2018 | 9.55 Mn |
| Dec 31, 2017 | 9.12 Mn |
| Sep 30, 2017 | 6.59 Mn |
| Jun 30, 2017 | 8.75 Mn |
| Mar 31, 2017 | 4.65 Mn |
| Dec 31, 2016 | 3.67 Mn |
| Sep 30, 2016 | 5.45 Mn |
| Jun 30, 2016 | 4.08 Mn |
| Mar 31, 2016 | 3.22 Mn |
| Dec 31, 2015 | 1.96 Mn |
| Sep 30, 2015 | 7.51 Mn |
| Jun 30, 2015 | 7.18 Mn |
| Mar 31, 2015 | 5.06 Mn |
| Dec 31, 2014 | 2.67 Mn |
| Sep 30, 2014 | 649,000.00 |
| Jun 30, 2014 | 2.61 Mn |
| Dec 31, 2013 | 2.35 Mn |